UPEXI, INC. Announces Board and Officer Changes
Ticker: UPXI · Form: 8-K · Filed: Apr 25, 2025 · CIK: 1775194
| Field | Detail |
|---|---|
| Company | Upexi, Inc. (UPXI) |
| Form Type | 8-K |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
UPEXI just swapped out some board members and execs, expect news on pay soon.
AI Summary
On April 24, 2025, UPEXI, INC. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes the election of new directors and the appointment of certain officers, alongside information on compensatory arrangements for these key individuals. The company, formerly known as GROVE, INC., is incorporated in Nevada and operates in the medicinal chemicals & botanical products sector.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, governance, or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty regarding future strategy and financial performance.
Key Numbers
- 001-40535 — SEC File Number (Identifies the company's filing history with the SEC.)
- 83-3378978 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- UPEXI, INC. (company) — Registrant
- GROVE, INC. (company) — Former Company Name
- April 24, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of Incorporation
- 3030 N. Rocky Point Drive, Suite 420 Tampa, FL 33607 (address) — Principal Executive Offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of new directors, but the specific names and details of their election are not provided in this excerpt.
Who are the newly appointed officers and what are their roles?
The filing mentions the appointment of certain officers, but their names and specific positions are not detailed in this section.
What is the nature of the compensatory arrangements for the new officers?
The filing states that information on compensatory arrangements is included, but the specifics of these arrangements are not elaborated upon in this excerpt.
When did UPEXI, INC. change its name from GROVE, INC.?
The company's name was changed from GROVE, INC. on April 29, 2019.
What is UPEXI, INC.'s primary business sector?
UPEXI, INC. operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, with SIC code 2833.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 25, 2025 regarding UPEXI, INC. (UPXI).